Electrolyte Imbalance As A Key Contributor To Unexplained Pain In Chronic Kidney Disease Patients Undergoing Haemodialysis: An Observational Study
Abstract
Background: Chronic kidney disease (CKD) patients on hemodialysis often experience unexplained pain, potentially exacerbated by electrolyte imbalances. This study aims to investigate the prevalence of pain in this population and its association with mineral levels, particularly phosphorus and calcium.
Methods: An observational study was conducted involving 62 CKD patients undergoing hemodialysis. Demographic data, pain prevalence, location, severity, and frequency were assessed using structured questionnaires. Blood urea, phosphorus, calcium, potassium, and creatinine levels were measured pre- and post-dialysis. Statistical analyses, including chi-square tests, were employed to explore relationships between mineral levels and pain characteristics.
Results: Of the participants, 66.13% reported experiencing pain, predominantly localized in the legs (40.32%) and arms (19.35%). The majority rated their pain as mild (58.53%) and reported it as occasional (87.80%). Notably, 53.23% exhibited elevated phosphorus levels, while 91.93% had low calcium levels. Chi-square analysis demonstrated significant associations between mineral imbalances and pain experiences (χ² = 167.51, p < 0.00001), highlighting a potential correlation between elevated phosphorus and low calcium levels with reported pain.
Discussion: This study underscores the high prevalence of pain among hemodialysis patients and the critical need for comprehensive pain assessment and management. The observed associations between electrolyte imbalances and pain suggest that careful monitoring of phosphorus and calcium levels may be essential for improving patient outcomes.
Conclusion: Electrolyte imbalances, particularly elevated phosphorus, and low calcium, significantly contribute to pain in CKD patients undergoing hemodialysis. Enhanced monitoring and targeted interventions to address these imbalances are crucial for improving pain management and overall quality of life in this vulnerable population.
References
Lee GI, Neumeister MW. Pain: pathways and physiology. Clinics in plastic surgery. 2020 Apr 1;47(2):173-80.
Djordjevic CM. Finding a meaning for pain: Definitions, sense‐making, and philosophical health. Journal of Evaluation in Clinical Practice. 2023 Oct;29(7):1196-202.
Melchior M, Kuhn P, Poisbeau P. The burden of early life stress on the nociceptive system development and pain responses. European Journal of Neuroscience. 2022 May;55(9-10):2216-41.
Sofue T, Nakagawa N, Kanda E, Nagasu H, Matsushita K, Nangaku M, Maruyama S, Wada T, Terada Y, Yamagata K, Narita I. Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PloS one. 2020 Oct 15;15(10):e0240402.
Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. The lancet. 2021 Aug 28;398(10302):786-802.
Mehmood HR, Khan Z, Jahangir HM, Hussain A, Elahi A, Askari SM. Assessment of serum biochemical derangements and associated risk factors of chronic kidney disease. Journal of Taibah University Medical Sciences. 2022 Jun 1;17(3):376-83.
Clase CM, Carrero JJ, Ellison DH, Grams ME, Hemmelgarn BR, Jardine MJ, Kovesdy CP, Kline GA, Lindner G, Obrador GT, Palmer BF. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2020 Jan 1;97(1):42-61.
Harding EK, Zamponi GW. Central and peripheral contributions of T-type calcium channels in pain. Molecular brain. 2022 May 2;15(1):39.
Yousuf MS, Maguire AD, Simmen T, Kerr BJ. Endoplasmic reticulum–mitochondria interplay in chronic pain: The calcium connection. Molecular Pain. 2020 Aug; 16:1744806920946889.
Wagner CA. The basics of phosphate metabolism. Nephrology Dialysis Transplantation. 2024 Feb;39(2):190-201.
Jacobson KA, Giancotti LA, Lauro F, Mufti F, Salvemini D. Treatment of chronic neuropathic pain: purine receptor modulation. Pain. 2020 Jul 1;161(7):1425-41.
Goldstein DL. Renal and extrarenal regulation of body fluid composition. InSturkie's avian physiology 2022 Jan 1 (pp. 411-443). Academic Press.
Rennke H, Denker BM. Renal pathophysiology: the essentials. Lippincott Williams & Wilkins; 2023 Dec 13.
Kayani A, Jamali A, Moorani K, Fatima S, Jamil A. Vitamin D deficiency in children with chronic kidney disease-Mineral Bone Disorder (CKD-MBD) and factors affecting response to cholecalciferol therapy: A quasi-experimental study from low-middle income setting. Caspian Journal of Pediatrics. 2022 Mar 10;8(1):615-24.
Wang YA, Rhemtulla M. Power analysis for parameter estimation in structural equation modeling: A discussion and tutorial. Advances in Methods and Practices in Psychological Science. 2021 Jan;4(1):2515245920918253.
De Ridder D, Adhia D, Vanneste S. The anatomy of pain and suffering in the brain and its clinical implications. Neuroscience & Biobehavioral Reviews. 2021 Nov 1; 130:125-46.
Dos Santos PR, Mendonça CR, Hernandes JC, Borges CC, Barbosa MA, de Sousa Romeiro AM, Alves PM, Dias NT, Porto CC. Pain in patients with chronic kidney disease undergoing hemodialysis: A systematic review. Pain Management Nursing. 2021 Oct 1;22(5):605-15.
Sun JK, Zhang WH, Zou L, Liu Y, Li JJ, Kan XH, Dai L, Shi QK, Yuan ST, Yu WK, Xu HY. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging (albany NY). 2020 Jun 6;12(12):11287.
Puntillo F, Giglio M, Paladini A, Perchiazzi G, Viswanath O, Urits I, Sabbà C, Varrassi G, Brienza N. Pathophysiology of musculoskeletal pain: a narrative review. Therapeutic advances in musculoskeletal disease. 2021 Feb; 13:1759720X21995067.
Serna J, Bergwitz C. Importance of dietary phosphorus for bone metabolism and healthy aging. Nutrients. 2020 Sep 30;12(10):3001.
Hou YC, Lu CL, Lu KC. Mineral bone disorders in chronic kidney disease. Nephrology. 2018 Oct; 23:88-94.
Bardin T. Musculoskeletal manifestations of chronic renal failure. Current opinion in rheumatology. 2003 Jan 1;15(1):48-54.
Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ, Komaba H, Ando R, Kakuta T, Fujii H, Nakayama M. Clinical practice guideline for the management of chronic kidney disease‐mineral and bone disorder. Therapeutic Apheresis and Dialysis. 2013 Jun;17(3):247-88.
Izzo C, Secondulfo C, Bilancio G, Visco V, Virtuoso N, Migliarino S, Ciccarelli M, Di Pietro P, La Mura L, Damato A, Carrizzo A. Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview. Life. 2024 Mar 21;14(3):418.
P.A Sreeja, V. J Dawn, M. Goutham Krishna, Roselit Mariya, C. Sayanth Raj, R. S Vismaya, An Overview of Assessment of Unexplained Pain: The Role of Mineral Imbalance and The Quality of Life in Chronic Kidney Failure Patients Undergoing Haemodialysis, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 6, 306-316. https://doi.org/10.5281/zenodo.11491103.
Joson CG, Henry SL, Kim S, Cheung MY, Parab P, Abcar AC, Jacobsen SJ, Morisky DE, Sim JJ. Patient-reported factors associated with poor phosphorus control in a maintenance hemodialysis population. Journal of Renal Nutrition. 2016 May 1;26(3):141-8.